Nanofibers offer alternative ways to the treatment of skin infections.
Injury to the skin causes a breach in the protective layer surrounding the body. Many pathogens are resistant to antibiotics, rendering conventional treatment less effective. This led to the use of alternative antimicrobial compounds, such as silver ions, in skin treatment. In this review nanofibers, and the incorporation of natural antimicrobial compounds in these scaffolds, are discussed as an alternative way to control skin infections. Electrospinning as a technique to prepare nanofibers is discussed. The possibility of using these structures as drug delivery systems is investigated.
Heunis
T D J
TD
Department of Microbiology, University of Stellenbosch, Matieland, Stellenbosch 7602, South Africa.
Dicks
L M T
LM
D000890:Anti-Infective Agents / Q000737:chemistry* / Q000627:therapeutic use*; D016503:Drug Delivery Systems; D057139:Nanofibers / Q000737:chemistry* / Q000627:therapeutic use*; D036103:Nanotechnology / Q000379:methods*; D012834:Silver; D012867:Skin / Q000293:injuries / Q000382:microbiology; D012874:Skin Diseases, Infectious / Q000188:drug therapy*
D000890:Anti-Infective Agents; D012834:Silver
Burns. 1996 Jun;22(4):279-82
8781719
J Mater Sci Mater Med. 2008 Feb;19(2):827-32
17665113
Biotechnol Bioeng. 1994 Aug 20;44(5):636-41
18618799
Burns. 2004 Nov;30(7):660-4
15475138
Antimicrob Agents Chemother. 2009 Feb;53(2):393-400
19015341
Burns. 1996 Jun;22(4):283-6
8781720
FEMS Microbiol Rev. 1993 Sep;12(1-3):39-85
8398217
Ann Surg. 1972 Jul;176(1):108-10
5037810
World J Surg. 1998 Feb;22(2):135-45
9451928
Nat Rev Microbiol. 2005 Oct;3(10):777-88
16205711
J Bacteriol. 1991 Jun;173(12):3879-87
1904860
J Antimicrob Chemother. 1997 Jul;40(1):135-6
9249217
Burns. 2004 Jul;30 Suppl 1:S1-9
15327800
J Control Release. 2003 Apr 29;89(2):341-53
12711456
Epidemiol Infect. 1997 Feb;118(1):1-5
9042029
Science. 1992 Aug 21;257(5073):1064-73
1509257
Clin Microbiol Rev. 2006 Apr;19(2):403-34
16614255
J Control Release. 2008 Apr 21;127(2):180-7
18314212
Biomacromolecules. 2008 Jan;9(1):349-54
18067266
Burns. 1992 Aug;18(4):332-5
1418512
J Bacteriol. 1997 Oct;179(19):6127-32
9324262
Ann Acad Med Singap. 1992 Sep;21(5):664-6
1292397
Antimicrob Agents Chemother. 1989 Apr;33(4):437-41
2499249
Appl Environ Microbiol. 1993 Nov;59(11):3577-84
8285666
Appl Environ Microbiol. 1993 May;59(5):1416-24
16348933
Biomacromolecules. 2005 Jul-Aug;6(4):2017-24
16004440
Adv Drug Deliv Rev. 2007 Dec 10;59(14):1392-412
17884240
Burns. 2004 Jun;30(4):357-61
15145194
Burns. 2004 Mar;30(2):140-7
15019121
ACS Nano. 2009 Feb 24;3(2):279-90
19236062
J Hosp Infect. 1994 Mar;26(3):157-65
7911481
Microbiol Immunol. 1995;39(8):531-43
7494490
J Hosp Infect. 1991 Sep;19 Suppl B:19-25
1684187
Small. 2009 Jul;5(13):1553-61
19326357
J Control Release. 2004 Jul 23;98(1):47-56
15245888
Antimicrob Agents Chemother. 1989 Aug;33(8):1358-61
2508545
J Control Release. 2002 May 17;81(1-2):57-64
11992678
Curr Opin Infect Dis. 2004 Apr;17(2):91-6
15021046
Int J Pharm. 2007 Jun 29;338(1-2):276-83
17321084
J Burn Care Rehabil. 1992 Mar-Apr;13(2 Pt 1):198-202
1587917
Int J Pharm. 2004 Dec 9;287(1-2):163-73
15541923
Crit Rev Microbiol. 2008;34(1):43-69
18259980
Biotechnol Bioeng. 2008 Mar 1;99(4):996-1006
17879301
Toxicol Lett. 2008 Jul 10;179(3):130-9
18547751
Biomaterials. 2009 Feb;30(5):780-8
19012962
Burns. 2009 Jun;35(4):553-60
19167827
Appl Environ Microbiol. 2000 Jun;66(6):2565-71
10831439
FEMS Microbiol Rev. 2001 May;25(3):285-308
11348686
Probiotics Antimicrob Proteins. 2010 Mar;2(1):46-51
26780900
Int J Pharm. 2008 Dec 8;364(2):281-97
18538517
Nanotechnology. 2006 Sep 28;17(18):4675-81
21727596
Science. 2001 Nov 23;294(5547):1684-8
11721046
Inhal Toxicol. 2008 Apr;20(6):567-74
18444009
Nanomedicine. 2009 Mar;5(1):46-54
18824416
Antimicrob Agents Chemother. 1989 Jul;33(7):991-4
2675759
J Hosp Infect. 2003 Jan;53(1):6-13
12495679
J Control Release. 2003 Oct 30;92(3):227-31
14568403
Burns. 2007 Dec;33(8):1008-14
17996555
Neurochem Int. 2009 Feb;54(2):73-83
19084565
J Burn Care Rehabil. 2005 Jan-Feb;26(1):53-6
15640735
Microbiol Rev. 1995 Jun;59(2):171-200
7603408
J Clin Microbiol. 1999 Jun;37(6):1771-6
10325322
J Control Release. 2005 Nov 28;108(2-3):237-43
16153737
J Ind Microbiol Biotechnol. 2006 Jul;33(7):627-34
16761169
J Antimicrob Chemother. 1996 Feb;37(2):243-51
8707734
Science. 1999 May 21;284(5418):1318-22
10334980
Annu Rev Microbiol. 1998;52:41-79
9891793
Int J Food Microbiol. 1995 Dec;28(2):169-85
8750665
Probiotics Antimicrob Proteins. 2010 Jun;2(2):61-5
26781114
Br Med J. 1979 Feb 17;1(6161):446-9
106914
Biomacromolecules. 2008 Jul;9(7):2087-90
18576601
J Control Release. 2006 Sep 28;115(1):18-25
16962196
Antonie Van Leeuwenhoek. 1999 Jul-Nov;76(1-4):185-98
10532378
JAMA. 1968 Mar 18;203(12):1054-6
5694367
J Wound Care. 2002 May;11(5):173-7
12055941
J Antimicrob Chemother. 2004 Sep;54(3):648-53
15282239
Ann Surg. 1976 Apr;183(4):358-64
1267492
Burns. 1998 Mar;24(2):91-8
9625231
Burns. 1995 Dec;21(8):575-9
8747728
J Trauma. 1987 Feb;27(2):213-6
3820354
Adv Funct Mater. 2007;17(8):1288-1296
18618021